• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT; CORONARY DRUG-ELUTING STENT Back to Search Results
Lot Number 2101741
Patient Problems Myocardial Infarction (1969); Rash (2033); Swelling/ Edema (4577)
Event Date 03/10/2023
Event Type  Injury  
Event Description
On date above had major heart attack with stent placed.15 days later had another heart attack & another stent placed which was 90% blocked at the time of my first heart attack.(b)(6) 2023 they put me on brilinta.I got a rash that looked like sun poisoning almost immediately also swelling across my nose with lots of snot going down my throat & my throat closing/swelling up.Now here eight months later the "rash" is extreme & has overtaken my whole body almost.It just started out on one of my forearms.On (b)(6) 2023 doctors added norvasc to my medications & and that's when we noticed the rash became unbearable.It's still going on & not really healing up.But some doctors seen have acted very concerned & some have acted like it's no big deal.Reference report: mw5149001.Refer to add'l documents in i2k.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
ABBOTT VASCULAR
MDR Report Key18290762
MDR Text Key330226405
Report NumberMW5149000
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 12/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Lot Number2101741
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/07/2023
Patient Sequence Number1
Treatment
2 STENTS; AMLODIPINE BESYLATE; ASPIRIN 81MG; ATORVASTATIN 80MG; BRILINTA; ISOSORBIDE MONONITRATE 30MG; LOSARTAN 100M; METOPROLOL SUCCINATE ER 50MG; NITRO0.4MG; NORVASC; PREDNISONE 50MG - 5MG TAPERING; TYLENOL.... MAYBE ONCE A MONTH
Patient Outcome(s) Life Threatening; Other;
Patient Age50 YR
Patient SexMale
Patient Weight98 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-